{"name":"Avizorex Pharma, S.L.","slug":"avizorex-pharma-s-l","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AVX012 Ophthalmic Solution Low dose","genericName":"AVX012 Ophthalmic Solution Low dose","slug":"avx012-ophthalmic-solution-low-dose","indication":"Other","status":"phase_1"},{"name":"AVX012 Ophthalmic Solution High dose","genericName":"AVX012 Ophthalmic Solution High dose","slug":"avx012-ophthalmic-solution-high-dose","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AVX012 Ophthalmic Solution Low dose","genericName":"AVX012 Ophthalmic Solution Low dose","slug":"avx012-ophthalmic-solution-low-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AVX012 Ophthalmic Solution High dose","genericName":"AVX012 Ophthalmic Solution High dose","slug":"avx012-ophthalmic-solution-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNZEQ5V0JNMnQ5ckRZODdNeDd5M3E4UEprNk5sX0RSaGNqdFlvVDYzVkF6SzNVRDQ4bEtldWJoZUJtUlJORFJ3eHdONXFjeWRqWGJBM1c5Vkcwa3VkQmlfazRaYVA3MEVDWUVoVGFJbDZCcjRKTWlsdTkxeEg5TVluOVR1aHZ0UTdrZXllUTQ2Wk1RZGFFVlJFYUJJd2w?oc=5","date":"2022-11-07","type":"pipeline","source":"El Referente","summary":"Innerva Pharmaceuticals levanta 2,3M€ en una ronda de inversión - El Referente","headline":"Innerva Pharmaceuticals levanta 2,3M€ en una ronda de inversión","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}